International Journal of Clinical Pharmacy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2025-01-16 重复的用户名来自浙江省

投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？

14 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2024-01-15 1209cfa0m30暂无昵称来自北京

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：临床药学;药物警戒
经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。

100 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2022-12-14 ms7000000331646088 来自吉林省

该杂志的检查表在哪里找呀

0 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

引言中是否可以引用非常老的文章？

131 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2021-12-27 Mia

引言和讨论的区别？

121 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2020-03-17 ms9526231670310936

审稿速度:1.0
经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受

179 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2019-08-12 胡葱葱

审稿速度:6.0 | 投稿命中率:75.0
经验分享：请问pubmed搜索得到之后多久才可以被SCI收录

194 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2017-07-14 qiqi

从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有

351 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2016-05-11 lovetcm

所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！
另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的

357 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2248313, encodeId=0e79224831346, content=投稿到今天正好4个月，目前还是Reviewers Assigned状态，有没有哪位道友可以分享经验的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Jan 16 11:24:21 CST 2025, time=2025-01-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181829, encodeId=251621818291b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床药学;药物警戒 经验分享：9月15日投稿，因为格式问题迅速被编辑要求重新提交。同行Review到12月初，期间应该是更换了一个审稿人。12月中旬被要求大修，月底返回后1月中旬接收。总体速度较快，编辑和审稿人认真负责，可以考虑投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdac2193924, createdName=1209cfa0m30暂无昵称, createdTime=Mon Jan 15 17:20:21 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2106010, encodeId=2908210601076, content=该杂志的检查表在哪里找呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68df8200424, createdName=ms7000000331646088, createdTime=Wed Dec 14 14:22:34 CST 2022, time=2022-12-14, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1104353, encodeId=9f8d110435318, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104354, encodeId=8a491104354d2, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858499, encodeId=6a6c8584994c, content=审稿速度:1.0 经验分享：非常迅速的一个期刊，新颖、有价值的东西就容易被接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Tue Mar 17 17:23:39 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574700, encodeId=20dd5e47003d, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：请问pubmed搜索得到之后多久才可以被SCI收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43121942063, createdName=胡葱葱, createdTime=Mon Aug 12 16:21:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542319, encodeId=6f16542319d6, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522247, encodeId=056852224e2c, content=所谓的IJPT是International Journal of Pharmacy and Therapeutics，是印度人做的网站（但实际上有可能有XX国人参与）。大家千万担心，这个网站做得象真杂志一样，发表文章在290美金！ 另外还有一个Research Journal of Pharmaceutical, Biological and Chemical Sciences，发表文章需要350美金，也是假的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:44:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522246, encodeId=417c52224674, content=INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=509, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed May 11 09:39:00 CST 2016, time=2016-05-11, status=1, ipAttribution=)]

2016-05-11 lovetcm

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY这是正牌杂志，而International Journal of Pharmacy and Therapeutics 这个是假冒杂志！大家一定要注意识别，通过MedSci打开的主页，都是真实的，如果通过其它搜索引擎打开，有可能是假的（google一般都比较造谱）。MedSci的搜索是模糊匹配的，名称相近，千万不要混了

509 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务